Skip to main content
SpringerLink
Log in

Effects on the Metabolism

  • Chapter
Book cover Adrenergic Activators and Inhibitors

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 54 / 1))

Abstract

A very extensive literature has accumulated on the metabolic effects of the catecholamines. Most of these metabolic effects were known in their gross outlines, or in interesting heuristic publications, when the field was first reviewed in detail (Ellis, 1956). In the subsequent decades interest in the field spread as questions raised by effects of catecholamines and other agents on metabolism stimulated the development of new knowledge of the cellular mechanisms of metabolic control processes. Further expansion was stimulated by the introduction of the clinically important, selective β- adrenoceptor antagonists and the more selective Mβ-agonists. Progress in the field has been well summarized in broad, general reviews (Wenke, 1965; Himms-Hagen, 1967; Ellis, 1967; Lundholm et al., 1966; Robison et al., 1971; Himms-Hagen, 1972).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abraham, R.R., Dade, E., Elliot, J., Hems, S.: Hormonal control of intermediary metabolism in obese hyperglycemic mice. II. Levels of plasma free fatty acid and immunoreactive insulin and liver glycogen. Diabetes 20, 535–541 (1971)

    PubMed  CAS  Google Scholar 

  • Altszuler, N., Rathgeb, I., Steele, R.: Mechanisms responsible for the hyperglycemia produced by the dibutyryl derivative of cyclic 3’,5’-adenosine monophosphate. Biochem. Pharmacol. 20, 2813–2819 (1971)

    Article  PubMed  CAS  Google Scholar 

  • Altszuler, N., Gottlieb, B., Steele, R., Bjerknes, C.: Metabolic effects of stimulation of alpha and beta adrenergic receptors in the dog. Fed. Proc. 33, 486 (1974)

    Google Scholar 

  • Altszuler, N., Gottlieb, B., Hampshire, J.: Interaction of somatostatin, glucagon, and insulin on hepatic glucose output in normal dog. Diabetes 25, 116–121 (1976)

    Article  PubMed  CAS  Google Scholar 

  • Altszuler, N., Moraru, E., Gottlieb, B., Hampshire, J.: Effect of isoproterenol on glucose turnover and insulin secretion in the normal dog. Biochem. Pharmacol. 27, 769–772 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Antonis, A., Clark, M.L., Hodge, R.L., Molony, M., Pilkington, T.R.E.: Receptor mechanisms in the hyperglycemic response to adrenaline in man. Lancet I, 1135–1137 (1967)

    Google Scholar 

  • Arnold, A., McAuliff, J.P.: Positive correlation of responsiveness to catecholamines of the rat liver glycogenolytic receptor with other α-receptor responses. Experentia 24, 674–675 (1968)

    Article  CAS  Google Scholar 

  • Arnold, A., McAuliff, J.P.: α-Receptor mediated hyperglycemia in the mouse. Arch. Int. Pharmacodyn. Ther. 189, 243–249 (1971)

    CAS  Google Scholar 

  • Arnold, A., Selberis, W.H.: Activities of catecholamines on the rat muscle glycogenolytic (β-2) receptor. Experientia 24, 1010–1011 (1968)

    Article  PubMed  CAS  Google Scholar 

  • Arnold, A., McAuliff, J.P., Colella, D.F., O’Connor, W.V., Brown, Th. G. Jr.: The β-2 receptor mediated glycogenolytic responses to catecholamines in the dog. Arch. Int. Pharmacodyn. Ther. 176, 451–457 (1968)

    PubMed  CAS  Google Scholar 

  • Assimacopoulos-Jeannet, F.D., Blackmore, P.F., Exton, J.: Studies on a-adrenergic activation of hepatic glucose output. Studies on role of calcium in a-adrenergic activation of phosphorylase. J. Biol. Chem. 252, 2662–2669 (1977)

    PubMed  CAS  Google Scholar 

  • Baker, L., Barcai, A., Kaye, R., Haque, N.: Beta adrenergic blockade and juvenile diabetes: acute studies and long-term therapeutic trial. Evidence for the role of catecholamines in mediating diabetic decompensation following emotional arousal. J. Pediatr. 75, 19–29 (1969)

    Article  PubMed  CAS  Google Scholar 

  • Barrett, A.M.: The mobilization of free fatty acids in response to isoprenaline in the rat. Br. J. Pharmacol. 25, 545–556 (1965)

    CAS  Google Scholar 

  • Barrett, A.M., Crowther, A.F., Dunlop, D., Shanks, R.G., Smith, L.H.: Cardioselective β- blockade. Naunyn-Schmiedebergs Arch. Pharmakol. exp. Pathol. 259, 152–153 (1967–68)

    Google Scholar 

  • Berlan, M.: Effect du jeüone et de l’hypophysectomie sur l’action lipolytique et hyperglycemiante de Padrénaline chez le chin traité par un béta-bloquant. C.R. Soc. Biol. 168, 117–130 (1974)

    CAS  Google Scholar 

  • Berlan, M.: Effet d’adrénoly tiques alpha ou beta sur la mobilisation catécholaminergique des acides gras libres plasmatiques chez le chien intact ou surrenalectomisé. Arch. Farmacol. Toxicol. II, 85–96 (1976)

    Google Scholar 

  • Berlan, M., Dang Tran, L.: Intervention de récepteurs adrénergiques alpha et béta dans l’effect des catecholamines sur la lipolyse d’adipocytes de chien. J. Physiol. (Paris) 74, 601–608 (1978)

    CAS  Google Scholar 

  • Berlan, M., Lafontan, M.: Etude d’un tissu adipeux humain insensible a l’action lipolytique de l’adrenaline. Role des récepteurs alpha adrenergiques. J. Physiol. (Paris) 73, 90 A (1977)

    Google Scholar 

  • Bressler, R., Vargas-Cordon, M., Lebovitz, H.F.: Tranylcypromine: A potent insulin secretagogue and hypoglycemic agent. Diabetes 17, 617–624 (1968)

    PubMed  CAS  Google Scholar 

  • Brody, T.M., McNeill, J.H.: Adrenergic receptors for metabolic responses in skeletal and smooth muscles. Fed. Proc. 29, 1375–1378 (1970)

    PubMed  CAS  Google Scholar 

  • Brooker, W.D., Calvert, D.N.: Blockade of catecholamine mediated release of free fatty acids from adipose tissue in vitro. Arch. Int. Pharmacodyn. Ther. 169, 117–130 (1967)

    PubMed  CAS  Google Scholar 

  • Burns, J.J., Lemberger, L.: N-tertiary butyl methoxamine, a specific antagonist of the metabolic actions of epinephrine. Fed. Proc. 24, 298 (1965)

    Google Scholar 

  • Burns, J.J., Colville, K.I., Lindsay, L.A., Salvador, R.A.: Blockade of some metabolic effects of catecholamines by N-isopropyl methoxamine (B.W. 61–43). J. Pharmacol. Exp. Ther. 114, 163–171 (1964)

    Google Scholar 

  • Burns, T.W., Langley, P.E.: Lipolysis by human adipose tissue: The role of cyclic 3’,5’- adenosine monophosphate and adrenergic receptor sites. J. Lab. Clin. Med. 75, 983–997 (1970)

    PubMed  CAS  Google Scholar 

  • Burns, T.W., Langley, P.E.: Differential effects of α and β adrenergic blocking agents on basal and stimulated lipolysis of human and rat isolated adipose tissue cells. Pharmacol. Res. Commun. 3, 271–277 (1971)

    Article  CAS  Google Scholar 

  • Burns, T.W., Mohs, J.M., Langley, P.E., Yawn, R., Chase, G.R.: Regulation of human lipolysis. In vivo observations on the role of adrenergic receptors. J. Clin. Invest. 53, 338–341 (1974)

    Google Scholar 

  • Carlström, S., Westling, H.: Metabolic, circulatory and respiratory effects of a new sympathomimetic beta-receptor-stimulating agent, terbutaline, compared with orciprenaline. Acta Med. Scand. 512, 33–40 (1970)

    Google Scholar 

  • Chan, P.S., Ellis, S., Mühlbachova, E.: Differences in dihydroergotamine antagonism of glucose release by catecholamines, glucagon and adenosine 3’,5’-monophosphate in rabbit liver slices. Br. J. Pharmacol. 53, 593–597 (1978)

    Google Scholar 

  • Chen, G., Portman, R., Russel, D., Ensor, C.R.: Comparative pharmacology of arterenol, epinephrine, and isopropylarterenol. J. Am. Pharm. Assoc. 40, 273–276 (1951)

    CAS  Google Scholar 

  • Cherrington, A., Assimacopoulos, F., Harper, J., Corbin, J., Park, Ch., Exton, J.: Studies on the α-adrenergic activation of hepatic glucose output. II. Investigation of the roles of adenosine 3’:5’-monophosphate and adenosine 3’: 5’-monophosphate-dependent protein- kinase in the actions of phenylephrine in isolated hepatocytes. J. Biol. Chem. 251, 5209–5218 (1976)

    PubMed  CAS  Google Scholar 

  • Cheymol, G., Honnorat, C., Schmitt, H.: Pharmacological effects of two new β-adrenoceptor blocking drugs: Kö 1366 and Kö 1313. Eur. J. Pharmacol. 17, 341–351 (1972)

    Article  PubMed  CAS  Google Scholar 

  • Churchill, P.C., Belloni, F.L., Churchill, M.C.: Net renal glucose release in the rat. Am. J. Physiol. 225, 528–531 (1973)

    PubMed  CAS  Google Scholar 

  • Cole, J., Achou, C.J., Hetenyi, G., Jr.: Lack of an increase in endogenous glucose production during insulin-induced hypoglycemia in the rat. Endocrinology 93, 1438–1441 (1973)

    Article  PubMed  CAS  Google Scholar 

  • Correll, J.W.: Adipose tissue: ability to respond to nerve stimulation in vitro. Science 140, 387–389 (1963)

    Article  PubMed  CAS  Google Scholar 

  • Daniel, E.E., Paton, D.M., Taylor, G.S., Hodgson, B.J.: Adrenergic receptors for catechol-amine effects on tissue electrolytes. Fed. Proc. 29, 1410–1425 (1970)

    PubMed  CAS  Google Scholar 

  • Darwish, S.A.E., Furman, B.L.: Effects of levodopa and dopamine on plasma glucose concentration in mice. Eur. J. Pharmacol. 41, 351–360 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Desbals, B., Agid, R., Desbals, P.: Rôle des catecholamines dans la mobilisation des lipides chez le lapin surrenlectomise. J. Physiol. (Paris) 61, (Suppl. 2), 264 (1969)

    Google Scholar 

  • De Wulf, H., Keppens, S.: Is calcium the second messenger in liver for cyclic AMP-independent glycogenolytic hormones ? Arch. Int. Physiol. Biochim. 84, 159–160 (1976)

    PubMed  Google Scholar 

  • Dzedin, T., Lundholm, L., Svedmyr, N.: Relationship between some metabolic effects of nicotinic acid and catecholamines in the rabbit. Acta Pharmacol. Toxicol. 26, 446–460 (1968)

    CAS  Google Scholar 

  • Ellis, S.: The metabolic effects of epinephrine and related amines. Pharmacol. Rev. 8, 485–562 (1956)

    PubMed  CAS  Google Scholar 

  • Ellis, S.: The effects of sympathomimetic amines and adrenergic blocking agents on metabolism. In: Physiological Pharmacology. Root, W.S., Hofmann, F.G. (eds.), Vol. IV, pp. 179–241. New York: Academic Press 1967

    Google Scholar 

  • Ellis, S.: Récepteurs adrénergiques impliqués dans les responses métaboliques aux catécholamines. Actual. Pharmacol. (Paris) 25, 91–114 (1972)

    CAS  Google Scholar 

  • Ellis, S.: Some explanations for species differences in hyperglycemic responses to adrenergic agents. Life Sci. 22, 1229–1236 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Ellis, S., Anderson, H.L., Jr.: The effect of amines on the blood sugar of the rat. J. Pharmacol. Exp. Ther. 101, 92–100 (1951)

    PubMed  CAS  Google Scholar 

  • Ellis, S., Davis, A.H., Anderson, H.L., Jr.: Effects of epinephrine and related amines on contraction and glycogenolysis of the rat’s diaphragm. J. Pharmacol. Exp. Ther. 115, 120–125 (1955)

    PubMed  CAS  Google Scholar 

  • Ellis, S., Kennedy, B.L., Eusebi, A.J., Vincent, N.H.: Autonomic control of metabolism. Ann. NY Acad. Sci. 139 (3), 826–832 (1967)

    Article  PubMed  CAS  Google Scholar 

  • Ellis, S., Kempen, R.R., Potter, D.E.: Metabolic response to catecholamines in baboons and monkeys. Abstr. VI Int. Congr. Pharmacol., Helsinki 1975

    Google Scholar 

  • Exton, J.H., Harper, S.: Role of cyclic AMP in the actions of catecholamines on hepatic carbohydrate metabolism. Adv. Cyclic Nucleotide Res. 5, 519–531 (1975)

    PubMed  CAS  Google Scholar 

  • Exton, J.H., Park, C.R.: The role of cyclic AMP in the control of liver metabolism. In: Advances in enzyme regulation. Weber, G. (ed.), Vol. 6, p. 391. New York: Pergamon Press 1968

    Google Scholar 

  • Exton, J.H., Mallette, L.E., Jefferson, L.S., Wong, E.H.A., Friedmann, N., Miller, T.B. Jr., Park, C.R.: The hormonal control of hepatic gluconeogenesis. Recent Prog. Horm. Res. 26, 411–461 (1970)

    CAS  Google Scholar 

  • Fain, J.N.: Adrenergic blockade of hormone-induced lipolysis in isolated fat cells. Ann. N.Y. Acad. Sci. 139, 879–890 (1967)

    Article  PubMed  CAS  Google Scholar 

  • Fain, J.N.: Biochemical aspects of drug and hormone action on adipose tissue. Pharmacol. Rev. 25, 67–118 (1973)

    PubMed  CAS  Google Scholar 

  • Fain, J.N., Galton, D.J., Kovacev, V.P.: Effect of drugs on the lipolytic action of hormones in isolated fact cells. Mol. Pharmacol. 2, 237–247 (1966)

    PubMed  CAS  Google Scholar 

  • Fleming, W.E., Kenny, A.D.: The effect of fasting on the hyperglycaemic responses to catecholamines in rats. Br. J. Pharmacol. 22, 267–274 (1964)

    CAS  Google Scholar 

  • Fredholm, B., Lunell, N.O., Persson, B., Wagner, J.: Actions of salbutamol in late pregnancy: plasma cyclic AMP, insulin and C-peptide, carbohydrate and lipid metabolism in diabetic and non-diabetic women. Diabetologia 14, 235–242 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Gerich, J.B., Langlois, M., Noacco, C., Schneider, V., Forsham, P.H.: Adrenergic modulation of pancreatic glucagon secretion in man. J. Clin. Invest. 53, 1441–1446 (1974)

    Article  PubMed  CAS  Google Scholar 

  • Gerich, J.E., Lorenzi, M., Tsalikian, E., Karam, J.H.: Studies on mechanism of epinephrine- induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion. Diabetes 25, 65–71 (1976)

    Article  PubMed  CAS  Google Scholar 

  • Goldberg, R., Joffe, B.I., Bersohn, I., Van As, M., Kurt, L., Seftel, H.C.: Metabolic responses to selective beta-adrenergic stimulation in man. Postgrad. Med. J. 51, 53–58 (1975)

    Article  PubMed  CAS  Google Scholar 

  • Goodman, H.M., Bray, G.A.: Role of thyroid hormones in lipolysis. Am. J. Physiol. 210, 1053–1058 (1966)

    PubMed  CAS  Google Scholar 

  • Goodner, C.J., Koerker, D.J., Werrbach, J.H., Toivola, P., Gale, C.C.: Adrenergic regulation of lipolysis and insulin secretion in the fasted baboon. Am. J. Physiol. 224, 534–539 (1973)

    PubMed  CAS  Google Scholar 

  • Gothelf, B., Ellis, S.: Effects of propanolol and sotalol on epinephrine-induced hyperglycemia and glycogen depletion of liver and muscle in the rat. Proc. Soc. Exp. Biol. Med. 147, 259–262 (1974)

    PubMed  CAS  Google Scholar 

  • Håkanson, R., Lundquist, I., Rerup, C.: On the hyperglycaemic effect of dopa and dopamine. Eur. J. Pharmacol. 1, 114–119 (1967)

    Article  PubMed  Google Scholar 

  • Hampshire, J., Moraru, E., Altszuler, N.: On the mechanism of hyperglycemia and stimulation of growth hormone secretion by L-dopa. Pharmacology 17, 138–148 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Harris, W.S., Schoenfeld, C.D., Brooks, R.H., Weissler, A.M.: Receptor mechanisms for the metabolic and circulatory actions of epinephrine in man. 5. Clin. Invest. 44, 1058 (1965)

    Google Scholar 

  • Haylett, D.G., Jenkinson, D.H.: The receptors concerned in the actions of catecholamines on glucose release, membrane potential and ion movements in guinea-pig liver. J. Physiol. (Lond.) 225, 751–772 (1972)

    CAS  Google Scholar 

  • Himms-Hagen, J.: Sympathetic regulation of metabolism. Pharm. Rev. 19, 367–461 (1967)

    PubMed  CAS  Google Scholar 

  • Himms-Hagen, J.: Adrenergic receptors for metabolic responses in adipose tissue. Fed. Proc. 29, 1388–1401 (1970)

    PubMed  CAS  Google Scholar 

  • Himms-Hagen, J.: Effects of catecholamines on metabolism. In: Catecholamine. Handbook Exp. Pharmakol. Blaschko, H., Muscholl, E. (eds.). Vol. 33, pp. 365–462. Berlin, Heidelberg, New York: Springer 1972

    Google Scholar 

  • Hittelman, K.J., Butcher, R.W.: Effects of antilipolytic agents and α-adrenergic antagonists on cyclic AMP metabolism in hamster white adipocytes. Biochim. Biophys. Acta 316, 403–410 (1973)

    PubMed  CAS  Google Scholar 

  • Hornbrook, K.R.: Adrenergic receptors for metabolic responses in the liver. Fed. Proc. 29, 1381–1385 (1970)

    PubMed  CAS  Google Scholar 

  • Hornbrook, K.R., Brody, T.M.: The effect of catecholamines on muscle glycogen and Phosphorylase activity. J. Pharmacol. Exp. Ther. 140, 295–307 (1963 a)

    PubMed  CAS  Google Scholar 

  • Hornbrook, K.R., Brody, T.M.: Phosphorylase activity in rat liver and skeletal muscle after catecholamines. Biochem. Pharmacol. 12, 1407–1415 (1963 b)

    Google Scholar 

  • Hunninghake, D.B., Azarnoff, D.L., Waxman, D.: The effect of butoxamine on catecholamine-induced metabolic changes in humans. Clin. Pharmacol. Ther. 7, 470–476 (1966)

    PubMed  CAS  Google Scholar 

  • Hutcheon, D.E., P’an, S.Y., Gardocki, J.F., Jaeger, D.A.: The sympathomimetic and other pharmacological properties of DL 2-(l,2,3,4-tetrahydro-l-naphthyl)-imidazoline (tetrahydrozoline). J. Pharmacol. Exp. Ther. 113, 341–352 (1955)

    PubMed  CAS  Google Scholar 

  • Hutson, N., Brumley, F., Assimacopoulos, F.D., Harper, S., Exton, J.: Studies on the α-adrenergic activation of hepatic glucose output. I. Studies on the α-adrenergic activation of Phosphorylase and gluconeogenesis, and inactivation of glycogensynthase in isolated rat liver parenchimal cells. J. Biol. Chem. 251, 5200–5208 (1976)

    CAS  Google Scholar 

  • Irie, Y., Igawa, T., Hosokawa, T., Saitoh, Y.: Alterations in blood levels of carbohydrate and lipid metabolites and of cyclic AMP mediated by β1 and β2-adrenoceptors in beagle dogs: Effects of procaterol, a new selective β2-adrenoceptor agonist. Eur. J. Pharmacol. 53, 351–358 (1979)

    Article  PubMed  CAS  Google Scholar 

  • Jefferson, L.S., Exton, J.H., Butcher, R.W., Sutherland, E.W., Park, C.R.: Role of adenosine 3’,5’-monophosphate in the effects of insulin and antiinsulin serum on liver metabolism. J. Biol. Chem. 243, 1031–1038 (1968)

    PubMed  CAS  Google Scholar 

  • Jenkinson, D.H., Haylett, D.G., Koller, K.: Effects of catecholamines on the ionic permeability of cell membranes. In: Cell membrane receptors for drugs and hormones: A multidisciplinary approach, pp. 85–105. Straub, R.W., Bolis, L. (eds.) New York: Raven Press 1978

    Google Scholar 

  • Kelly, J.G., Shanks, R.G.: Adrenoceptors mediating metabolic responses in the greyhound. Br. J. Pharmacol. 41, 389 (1971)

    Google Scholar 

  • Kelly, J.G., Shanks, R.G.: Metabolic and cardiovascular effects of isoprenaline and salbutamol in the dog. Br. J. Pharmacol. 53, 157–162 (1975)

    PubMed  CAS  Google Scholar 

  • Kennedy, B.L., Ellis, S.: Interactions of sympathomimetic amines and adrenergic blocking agents at receptor sites mediating glycogenolysis. Fed. Proc. 22, 449 (1963)

    Google Scholar 

  • Kennedy, B.L., Ellis, S.: Interaction of sympathomimetic amines and adrenergic blocking agents at receptor sites mediating glycogenolysis in the rat. Arch. Int. Pharmacol. Ther. 177, 390–406 (1969 a)

    CAS  Google Scholar 

  • Kennedy, B.L., Ellis, S.: Interactions of sympathomimetic amines and adrenergic blocking agents at receptor sites mediating lipolysis in the rat. Proc. Soc. Exp. Biol. Med. 130, 1223–1229 (1969 b)

    Google Scholar 

  • Kennedy, B.L., Ellis, S.: Dissociation of catecholamine-induced calorigenesis from lipolysis and glycogenolysis in intact animals. J. Pharmacol. Exp. Ther. 168, 137–145 (1969c)

    PubMed  CAS  Google Scholar 

  • Krebs, E.G., DeLange, R.J., Kemp, R.G., Riley, W.D.: Activation of skeletal muscle Phos-phorylase. Pharmacol. Rev. 18, 163–171 (1966)

    PubMed  CAS  Google Scholar 

  • Kuo, S.H., Kamaka, J.K., Lum, B.K.B.: Adrenergic receptor mechanisms involved in the hyperglycemia and hyperlactic-acidemia produced by sympathomimetic amines in the cat. J. Pharmacol. Exp. Ther. 202, 301–309 (1977)

    PubMed  CAS  Google Scholar 

  • Kvam, D.C.: Adrenergic receptors for metabolic responses in muscle. Fed. Proc. 29, 1379–1380 (1970)

    PubMed  CAS  Google Scholar 

  • Kvam, D.C., Riggilo, D.A., Lish, P.M.: Effect of some new β-adrenergic blocking agents on certain metabolic responses to catecholamines. J. Pharmacol. 149, 183–191 (1965)

    CAS  Google Scholar 

  • Lafontan, M., Agid, R.: Alpha and beta adrenergic receptors in the regulation of rabbit white adipose tissue lipolysis. Comp. Biochem. Physiol. [C] 55, 85–90 (1976)

    Article  CAS  Google Scholar 

  • Lands, A.M., Arnold, A., McAuliff, J.P., Luduena, F.P., Brown, T.G. Jr.: Differentiation of receptor systems activated by sympathomimetic amines. Nature 214, 597–598 (1967)

    Article  PubMed  CAS  Google Scholar 

  • Lindsey, C.A., Faloona, G.R.: Adrenergic blockade in shock induced hyperglycemia. Diabetes 22, Suppl. 1, 301 (1973)

    Google Scholar 

  • Loakpradit, T., Lockwood, R.: Differentiation of metabolic adrenoceptors. Br. J. Pharmacol. 59, 135–140 (1977)

    PubMed  CAS  Google Scholar 

  • Lockwood, R.H., Lum, B.K.B.: Effects of adrenergic agonists and antagonists on potassium metabolism. J. Pharmacol. Exp. Ther. 189, 119–129 (1974 a)

    PubMed  CAS  Google Scholar 

  • Lockwood, R., Lum, B.K.B.: Selective adrenergic stimulant actions of l-isopropylamino-3(2-thiazoloxy)-2-propranol (IPT) in anesthetized cats. Life Sci. 14, 73–81 (1974 b)

    Google Scholar 

  • Loubatieres, A., Mariani, M.M., Chapal, J.: Insulino-sécrétion étudiée sue le pancreas et per- fusé du rat. II. Action des catécholamines et des substances loquant les récepteurs adrenergiques. Diabetologia 6, 533–541 (1970)

    Article  PubMed  CAS  Google Scholar 

  • Lundholm, L., Mohme-Lundholm, E., Svedmyr, M.: Metabolic effects of catecholamines. Introductory remarks. Pharmacol. Rev. 18, 255–272 (1966)

    PubMed  CAS  Google Scholar 

  • Lundquist, I.: Interaction of amines and aminergic blocking agents with blood glucose regulation. I. β-adrenergic blockade. Eur. J. Pharmacol. 18, 213–224 (1972 a)

    Google Scholar 

  • Lundquist, I.: Interaction of amines and aminergic blocking agents with blood glucose regulation. II. α-adrenergic blockade. Eur. J. Pharmacol. 18, 225–235 (1972 b)

    Article  PubMed  CAS  Google Scholar 

  • Lunell, N.O., Wager, J., Fredholm, B.B., Persson, B.: Metabolic effects of oral salbutamol in late pregnancy. Eur. J. Clin. Pharmacol. 14, 95 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Luyckx, A.S., Lefebvre, P.J.: Mechanisms involved in the exercise-induced increase in glucagon secretion in rats. Diabetes 23, 81–93 (1974)

    PubMed  CAS  Google Scholar 

  • Maling, H.M., Williams, M.A., Highman, B., Garbus, J., Hunter, J.: The influence of phenoxybenzamine and isopropylmethoxamine (BW 61-43) on some cardiovascular, metabolic, and histo-pathologic effects of norepinephrine infusions in dogs. Naunyn-Schmiedebergs Arch. Pharmakol. 248, 54–72 (1964)

    CAS  Google Scholar 

  • Maling, H.M., Cho, A.K., Horakova, Z., Williams, M.A.: The pharmacologic effects of ST-155 and related imidazolines in the rat. Pharmacology 2, 337–351 (1969)

    Article  PubMed  CAS  Google Scholar 

  • Malor, R., Chesher, G.B., Jackson, D.M.: The effect of Δ9-tetrahydrocannabinol on plasma concentrations of non-esterified fatty acids in the mouse. J. Pharm. Pharmacol. 28, 652–654 (1976)

    Article  PubMed  CAS  Google Scholar 

  • Mariani, M.M., Chapal, J., Loubatieres, A.: Isoprénaline, propranolol et insulino sécrétion. Etude sur le pancréas isolé et perfusé du rat. C. R. Soc. Biol. 163, 2390–2395 (1969)

    CAS  Google Scholar 

  • Mariani, M.M., Loubatieres, A., Chapal, J., Savi, L., Sorel, G.: Différenciation par le practolol du type de récepteur β adrénergique impliqué dans l’insulinosécrétion. C.R. Soc. Biol. 164, 1596–1600 (1971 a)

    Google Scholar 

  • Mariani, M., Loubatieres, A., Sorel, G., Savi, L.: Étude, “in vivo” des activateurs ou bioqueurs béta-adrénergiques sur insulino-sécrétion. Differentiation pharmacologique du type de récepteur béta impliqué. Diabete Metab. 19, 129–133 (1971b)

    CAS  Google Scholar 

  • Marshall, N.B., Engel, F.L.: The influence of epinephrine and fasting on adipose tissue content and release of free fatty acids in obese-hyperglycemic and lean mice. Lipid Res. 1, 339–342 (1960)

    CAS  Google Scholar 

  • Masoro, E.J.: Lipids and lipid metabolism. Annu. Rev. Physiol. 39, 301–321 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Massara, F., Fassio, V., Camanni, F., Molinatti, G.M.: Salbutamol-induced increase in plasma insulin in man. Horm. Metab. Res. 7, 94 (1975)

    Article  CAS  Google Scholar 

  • Mayer, S., Moran, N.C., Fain, J.: The effect of adrenergic blocking agents on some metabolic actions of catecholamines. J. Pharmacol. Exp. Ther. 134, 18–27 (1961)

    PubMed  CAS  Google Scholar 

  • McChesney, E.W., McAuliff, J.P., Blumberg, H.: The hyperglycemic action of some analogs of epinephrine. Proc. Soc. Exp. Biol. Med. 71, 220–223 (1949)

    PubMed  CAS  Google Scholar 

  • McMahon, E.M., Andersen, D.K., Feldman, J.M., Schanberg, S.M.: Methamphetamine- induced insulin release. Science 174, 66–68 (1971)

    Article  PubMed  CAS  Google Scholar 

  • Mennear, J.H., Spratto, G.R., Miya, T.S.: The comparative glycemic effects of catecholamines in rats and mice. Toxicol. Appl. Pharmacol. 18, 835–840 (1971a)

    Article  PubMed  CAS  Google Scholar 

  • Mennear, J.H., Spratto, G.R., Miya, T.S.: Failure of beta-adrenergic blocking agents to antagonize the hyperglycemic effect of epinephrine in mice. Proc. Soc. Exp. Biol. Med. 137, 87–89 (1971b)

    PubMed  CAS  Google Scholar 

  • Miller, D.W., Allen, D O.: Antilipolytic activity of 4-(2-hydroxy-3-isopropylaminopropoxy acetanilide (practolol). Proc. Soc. Exp. Biol. Med. 136, 715–718 (1971)

    PubMed  CAS  Google Scholar 

  • Moore, K.E.: Effects of (+)-amphetamine on lactic acid concentrations in the tissues of aggregated mice. J. Pharm. Pharmacol. 18, 196–197 (1966)

    Article  PubMed  CAS  Google Scholar 

  • Moore, K.E., Sawdy, L.C., Shaul, S.R.: Effects of D-amphetamine on blood glucose and tissue glycogen levels of isolated and aggregated mice. Biochem. Pharmacol. 14, 197–204 (1965)

    Article  PubMed  CAS  Google Scholar 

  • Moratinos, J., Potter, D.E., Ellis, S.: The influence of propranolol on catecholamine-induced Arch. Farmacol. Toxicol. 4, 189–210 (1978)

    CAS  Google Scholar 

  • Moratinos, J., Potter, D.E., Ellis, S.: The influence of propanolol on catecholamine-induced changes in carbohydrate metabolism in the rabbit. Eur. J. Pharmacol. 32, 186–194 (1975)

    Article  PubMed  CAS  Google Scholar 

  • Moratinos, J., Ellis, S., Potter, D.E.: Catecholamine induced changes in plasma glucose and insulin levels in the unanesthetized rabbit. Pharmacology 15, 407–414 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Morita, S., Irie, Y., Saitoh, Y., Kohri, H.: Evaluation of a new beta-adrenergic blocking agent, carteolol, based on metabolic responses in rats -I. Blockade in vivo of epinephrine and isoproterenol-induced alterations of blood concentrations of carbohydrate and lipid intermediary metabolites. Biochem. Pharmacol. 25, 1837–1842 (1976)

    Article  Google Scholar 

  • Mühlbachová, E., Chan, P., Ellis, S.: Quantitative studies of glucose release from rabbit liver slices induced by catecholamines and their antagonism by propranolol and phentolamine. J. Pharmacol. Exp. Ther. 182, 370–377 (1972)

    PubMed  Google Scholar 

  • Mühlbachova, E., Misekova, D., Elisova, K., Wenkeová, J.: Lipid-mobilizing effects of adrenaline, noradrenaline, isoproterenol and isopropylnorsynephrine in rabbit adipose tissue in vivo. Physiol. Bohemoslov. 22, 503–512 (1973)

    PubMed  Google Scholar 

  • Murad, F., Chi, Y.-M., Rail, T.W., Sutherland, E.W.: Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3’,5’-phosphate by preparations from cardiac muscle and liver. J. Biol. Chem. 237, 1233–1238 (1962)

    PubMed  CAS  Google Scholar 

  • Nakano, J., Kusakari, T., Berry, J.L.: Effects of propranolol on the circulatory changes and mobilization of free fatty acids caused by isoproterenol. Arch. Int. Pharmacodyn. Ther. 164, 120–127 (1966)

    PubMed  CAS  Google Scholar 

  • Nash, C.B., Smith, R.D.: Alteration of norepinephrine response in the dog by dual adrenergic blockade. Eur. J. Pharmacol. 8, 310–314 (1969)

    Article  PubMed  CAS  Google Scholar 

  • Nash, C.B., Smith, R.D.: Blood sugar responses to epinephrine in the dog in the presence of dual adrenergic blockade. Eur. J. Pharmacol. 17, 34–38 (1972)

    Article  PubMed  CAS  Google Scholar 

  • Newton, N.E., Hornbrook, K.R.: Effects of adrenergic agents on carbohydrate metabolism of rat liver: activities of adenyl cyclase and glycogen phosphorylase. J. Pharmacol. Exp. Ther. 181, 479–488 (1972)

    PubMed  CAS  Google Scholar 

  • Osborn, D.: Comparison of the effects of selective a- and ¡3- receptor agonists on intracellular cyclic AMP levels and glycogen phosphorylase activity in guinea-pig liver. Br. J. Pharmacol. 55 (2), 286P (1975)

    PubMed  CAS  Google Scholar 

  • Osborn, D.: The alpha adrenergic receptor mediated increase in guinea-pig liver glycogenolysis. Biochem. Pharmacol. 27, 1315–1320 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Ostman, J., Efendic, S.: Catecholamines and metabolism of human adipose tissue. Acta Med. Scand. 187, 471–476 (1970)

    CAS  Google Scholar 

  • Otto, W., Taylor, T.G., York, D.A.: Glycerol release in vitro from adipose tissue of obese (ob/ob) mice treated with thyroid hormones. J. Endocrinol. 71, 143–155 (1976)

    Article  PubMed  CAS  Google Scholar 

  • Ozawa, H., Goto, M., Takahashi, M., Uematsu, T.: Effect of clonidine on plasma insulin level in mice. Folia Pharmacol. (Japan) 74, 383–388 (1978)

    CAS  Google Scholar 

  • Pilkington, T.R.E., Lowe, R.D., Robinson, B.F., Titterington, E.: Effect of adrenergic blockade on glucose and fatty-acid mobilisation in man. Lancet 2, 316–317 (1962)

    Article  PubMed  CAS  Google Scholar 

  • Pogatsa, G., Tamas, J., Dubecz, E.: Effect of catecholamines on insulin secretion and liver glycogenolysis in rat. Horm. Metab. Res. 10, 378–381 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Porte, D.: Beta adrenergic stimulation of insulin release in man. Diabetes 16, 150–155 (1967)

    PubMed  CAS  Google Scholar 

  • Porte, D., Jr., Williams, R.H.: Inhibition of insulin release by norepinephrine in man. Science 152, 1248–1250 (1966)

    Article  PubMed  CAS  Google Scholar 

  • Potter, D.E., Ellis, S.: Isoproterenol- and epinephrine-induced changes in blood glucose and tissue glycogen levels in normal and diabetic rats: The influence of alteration in endogenous insulin levels and state of nourishment. J. Pharmacol. Exp. Ther. 193, 576–584 (1975)

    PubMed  CAS  Google Scholar 

  • Potter, D.E., Moratinos, J.: Effect of propranolol on isoproterenol and epinephrine-induced hyperglycemias in anesthetized rabbits. Fed. Proc. 30, 1684 (1971)

    Google Scholar 

  • Potter, D.E., Moratinos, J., Ellis, S.: Isoproterenol and epinephrine induced hyperglycemias in rabbits: Effects of alloxan treatment and prandial state. Proc. Soc. Esp. Biol. Med. 139, 1242–1245 1972 )

    CAS  Google Scholar 

  • Potter, D.E., Moratinos, J., Ellis, S.: Comparative hyperglycemic responses to norepinephrine, salbutamol and glucagon in normal and alloxan-diabetic insulin-controlled rabbits. Arch. Int. Pharmacodyn. Ther. 209, 358–368 (1974 a)

    PubMed  CAS  Google Scholar 

  • Potter, D.E., Wilson, L.M., Ellis, S.: Isoproterenol-induced insulin release in normal rats and hyperglycemia in alloxan-diabetic rats: A preliminary report. Res. Commun. Chem. Pathol. Pharmacol. 7, 787–790 (1974b)

    PubMed  CAS  Google Scholar 

  • Potter, D.E., Kempen, R.R., Ellis, S.: Comparative metabolic and cardiovascular responses to isoproterenol, metaproterenol, salbutamol, and carbuterol in baboons. Pharmacologist 17, 223 (1975)

    Google Scholar 

  • Potter, D.E., Moratinos, J., Ellis, S.: Metabolic response to isoproterenol and epinephrine in the rabbit. Influence of state of nourishment, alloxan diabetes and pretreatment with propranolol. Biochem. Pharmacol. 26, 1065–1069 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Potter, D.E., Barnett, J.W., Woodson, L.C.: Catecholamine-induced changes in plasma glucose, glucagon and insulin in rabbits: Effects of somatostatin. Horm. Metab. Res. 10, 373–377 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Rehbinder, D., Deckers, W.: Stoffwechseleffekte des Catapresan. Naunyn-Schmiedebergs Arch. Pharmakol. 261, 162–175 (1968)

    CAS  Google Scholar 

  • Robison, G.A., Butcher, R.W., Sutherland, E.W.: The Catecholamines. In: Cyclic AMP. pp. 145–231. New York: Academic Press 1971

    Google Scholar 

  • Rosenqvist, U.: Inhibition of noradrenaline-induced lipolysis in hypothyroid subjects by increased-adrenergic responsiveness. An effect mediated through the reduction of cyclic AMP levels in adipose tissue. Acta Med. Scand. 192, 353–359 (1972)

    CAS  Google Scholar 

  • Rudman, D.: The adipokinetic action of polypeptide and amine hormones upon the adipose tissue of various animal species. J. Lipid Res. 4, 119–129 (1963)

    PubMed  CAS  Google Scholar 

  • Saitoh, Y., Irie, Y., Hosokawa, T., Igawa, T., Hashimura, F., Kohri, H.: Evaluation of a new β-adrenoceptor agonist, procaterol based on metabolic responses in rats. Biochem. Pharmacol. 27, 2531–2535 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Salvador, R.A., April, S.A., Lemberger, L.: Inhibition by butoxamine, propranolol and MJ 1999 of the glycogenolytic action of the catecholamines in the rat. Biochem. Pharmacol. 16, 2037–2041 (1967)

    Article  PubMed  CAS  Google Scholar 

  • Salvador, R.A., April, S.A., Lemburger, L.: Phentolamine activation of glycogenolysis in rat skeletal muscle. Biochem. Pharmacol. 17, 395–402 (1968)

    Article  PubMed  CAS  Google Scholar 

  • Sanders, J.P., Potter, D.E., Ellis, S., Bee, D.E., Grant, J.A.: Metabolic and cardiovascular effects of carbuterol and metaproterenol. J. Allergy Clin. Immunol. 60, 174–179 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Schmitt, H., Lucet, B.: Action du pindolol sur les activités métaboliques de l’adrénaline. C. R. Séanc. Soc. Biol. 164, 2193–2195 (1970)

    CAS  Google Scholar 

  • Sherline, P., Lynch, A., Glinsman, W.H.: Cyclic AMP and adrenergic receptor control of rat liver glycogen metabolism. Endocrinology 91, 680–690 (1972)

    Article  PubMed  CAS  Google Scholar 

  • Sokal, J.E., Sarcione, E.J.: Failure of physiological concentrations of epinephrine to affect glycogen-levels in the isolated rat liver. Nature 204, 881–883 (1964)

    Article  PubMed  CAS  Google Scholar 

  • Spitzer, J.A.: Dissociation of epinephrine-induced free fatty acid and glycerol release by adrenergic blocking drugs. Biochem. Pharmacol. 17, 2205–2213 (1968)

    Article  PubMed  CAS  Google Scholar 

  • Stanton, H.C.: Selective metabolic and cardiovascular beta receptor antagonism in the rat. Arch. Int. Pharmacodyn. Ther. 196, 246–258 (1972)

    PubMed  CAS  Google Scholar 

  • Stock, K., Westermann, E.: Effects of adrenergic blockade and nicotinic acid on the mobilization of free fatty acids. Life Sci. 4, 1115–1124 (1965)

    Article  PubMed  CAS  Google Scholar 

  • Sutherland, E.W., Cori, C.F.: Effect of hyperglycemic-glycogenolytic factor and epinephrine on liver phosphorylase. J. Biol. Chem. 188, 531–543 (1951)

    PubMed  CAS  Google Scholar 

  • Sutherland, E.W., Robison, G.A.: The role of cyclic-3’,5’-AMP in responses to catecholamines and other hormones. Pharmacol. Rev. 18, 145–164 (1966)

    PubMed  CAS  Google Scholar 

  • Sutherland, E.W., Oye, I., Butcher, R.W.: The action of epinephrine and the role of the adenyl cyclase system in hormone action. Rec. Prog. Horm. Res. 21, 623–646 (1965)

    PubMed  CAS  Google Scholar 

  • Svedmyr, N., Lundholm, L.: The influence of an adrenergic β-receptor blocking agent [DL-4- (2-isopropylamino-l-hydroxylethyl) methanesulphonanilide, MJ 1999] on some of the met¬abolic effects of adrenaline in man. Life Sci. 6, 21–29 (1967)

    Article  CAS  Google Scholar 

  • Thenen, S.W., Carr, R.H.: Effects of thyroxine, epinephrine and cold exposure on lipolysis in genetically obese (ob/ob) mice. Proc. Soc. Exp. Biol. Med. 159, 116–120 (1978)

    PubMed  CAS  Google Scholar 

  • Timsit, J., Giroud, J.P., Dechezlepretre, S., Lechat, P.: Recherches sur Taction anti-inflammatoire de l’adrenaline. Arch. Int. Pharmacodyn. Ther. 205, 153–172 (1973)

    PubMed  CAS  Google Scholar 

  • Townley, R.G., Daley, D., Selenke, W.: The effect of agents used in the treatment of bronchial asthma on carbohydrate metabolism and histamine sensitivity after beta-adrenergic blokkade. J. Allergy 45, 71–86 (1970)

    Article  PubMed  CAS  Google Scholar 

  • Trapold, J.H., Warren, M.R., Woodbury, R.A.: Pharmacological and toxicological studies on 2-[N-p’-tolyl-N-(m’-hydroxyphenyl)-aminomethyl]- imidazoline (C-7337), a new adrenergic blocking agent. J. Pharmacol. Exp. Ther. 100, 119–127 (1950)

    PubMed  CAS  Google Scholar 

  • Vogel-Chevalier, L., Hammer, W., Fluckiger, E.: Influence of dihydroergotamine on the lipolytic system of isolated dog fat cells. Experientia 27, 674–676 (1971)

    Article  PubMed  CAS  Google Scholar 

  • Wagner, H.: Metabolic effects. In: Ergot alkaloids. Berde, B., Schild, H.O. (eds.), Handbook Exp. Pharmakol., Vol. 49, pp. 691–717. Berlin, Heidelberg, New York: Springer 1978

    Google Scholar 

  • Wenke, M.: Metabolicke ucinky katecholovych aminy. (Metabolic actions of catecholamines.) Czechoslovak Academy of Sciences, Prague 1965

    Google Scholar 

  • Wenke, M.: Effects of catecholamines on lipid mobilization. Adv. Lipid. Res. 4, 69–105 (1966)

    PubMed  CAS  Google Scholar 

  • Wenke, M.: Adrenotropic drugs in lipid mobilization. In: Hormone and metabolic research, adipose tissue. Jeanrenaud, B., Hepp, D. (eds.), Suppl. 2, pp. 55–62. New York: Academic Press 1970

    Google Scholar 

  • Wenke, M., Lincová, D., Cepelik, J., Cernohorský, M., Hynie, S.: Some aspects of the actions of beta adrenergic blocking drugs on adrenergic lipid mobilization. N.Y. Acad. Sci. 139 (3), 860–878 (1967)

    Article  CAS  Google Scholar 

  • Wenkeova, J., Kuhn, E., Wenke, M.: Adrenergic lipolysis in human adipose tissue in vitro. Eur. J. Pharmacol. 30, 49–55 (1975)

    Article  PubMed  CAS  Google Scholar 

  • Wenkeova, J., Kuhn, E., Wenke, M.: Some adrenomimetic drugs affecting lipolysis in human adipose tissue in vitro. Eur. J. Pharmacol. 35, 1–7 (1976 a)

    Article  PubMed  CAS  Google Scholar 

  • Wenkeova, J., Kuhn, E., Wenke, M.: Some adrenergic β-blocking agents affecting lipolysis in human adipose tissue in vitro. Eur. J. Pharmacol. 37, 91–95 (1976 b)

    Article  PubMed  CAS  Google Scholar 

  • Williams, R.H., Ensinck, J.W.: Secretion, fates and actions of insulin and related products. Diabetes 15, 623–654 (1966)

    PubMed  CAS  Google Scholar 

  • Wilson, W.R., Theilen, E.O., Connor, W.E.: Metabolic effects of isoproterenol and propranolol in normal subjects before, during and after triiodothyronine-induced hypermetabolism. Proc. Soc. Exp. Biol. Med. 124, 298–303 (1967)

    PubMed  CAS  Google Scholar 

  • Woodson, L.C.: The role of increased glucagon release in the production of hyperglycemia by catecholamines. Ph. D. Dissertation, Univ. Texas Medical Branch, Galveston, Texas, USA, 1977

    Google Scholar 

  • Woodson, L.C., Potter, D.L.: Catecholamine-induced alterations in glucose homeostasis in baboons, dogs, rabbits, and rats: Comparative effects of somatostatin. Metabolism 27, Suppl. 1, 1441–1444 (1978)

    Google Scholar 

  • Woodson, L., Potter, D.E., Kempen, R.R., Ellis, S.: Metabolic responses to adrenergic drugs in the fasted baboon: correlation with effects on insulin and glucagon secretion. Fed. Proc. 35, 688 (1976)

    Google Scholar 

  • Woodson, L.C., Kempen, R.R., Bee, D.E., Potter, D.E.: Role of glucagon in the hyperglycemic responses to catecholamines in fasted baboons. Pharmacology 17, 221–226 (1978)

    Article  PubMed  CAS  Google Scholar 

  • Zsoter, T., Tom, H., Kraml, M., Dvornik, D.: Adrenergic beta receptors and plasma free fatty acids. J. Pharmacol. Exp. Ther. 152, 425–431 (1966)

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. S. Ellis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute of Pharmacology, University Medical School of Szeged, Dóm tér 12, H-6701, Szeged, Hungary

    Lászlo Szekeres

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ellis, S. (1980). Effects on the Metabolism. In: Szekeres, L. (eds) Adrenergic Activators and Inhibitors. Handbook of Experimental Pharmacology, vol 54 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67505-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-67505-8_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-67507-2

  • Online ISBN: 978-3-642-67505-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation